Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 6978625, 9 pages
http://dx.doi.org/10.1155/2016/6978625
Research Article

The Role of Metformin in Controlling Oxidative Stress in Muscle of Diabetic Rats

1Institute of Genetics and Biochemistry, Federal University of Uberlandia, 38400-902 Uberlandia, MG, Brazil
2Department of Physiology, Institute of Biomedical Sciences, Federal University of Uberlandia, 38400-902 Uberlandia, MG, Brazil

Received 4 March 2016; Revised 15 June 2016; Accepted 4 July 2016

Academic Editor: Silvana Hrelia

Copyright © 2016 Danielle Diniz Vilela et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. S. Echtay, “Mitochondrial uncoupling proteins-what is their physiological role?” Free Radical Biology and Medicine, vol. 43, no. 10, pp. 1351–1371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. K. Roberts and K. K. Sindhu, “Oxidative stress and metabolic syndrome,” Life Sciences, vol. 84, no. 21-22, pp. 705–712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Baynes, “Role of oxidative stress in development of complications in diabetes,” Diabetes, vol. 40, no. 4, pp. 405–412, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Kopprasch, D. Srirangan, S. Bergmann, J. Graessler, P. E. H. Schwarz, and S. R. Bornstein, “Association between systemic oxidative stress and insulin resistance/sensitivity indices—the PREDIAS study,” Clinical Endocrinology, vol. 84, no. 1, pp. 48–54, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. N. J. Pillon, M. L. Croze, R. E. Vella, L. Soulère, M. Lagarde, and C. O. Soulage, “The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress,” Endocrinology, vol. 153, no. 5, pp. 2099–2111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Nathan, J. B. Buse, M. B. Davidson et al., “Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes,” Diabetes Care, vol. 32, no. 1, pp. 193–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. G. Hardie, S. A. Hawley, and J. W. Scott, “AMP-activated protein kinase-development of the energy sensor concept,” Journal of Physiology, vol. 574, no. 1, pp. 7–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. G. Hardie, “Minireview: the AMP-Activated Protein Kinase Cascade: the key sensor of cellular energy status,” Endocrinology, vol. 144, no. 12, pp. 5179–5183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. H.-Y. Lee, D. Wei, and M. R. Loeken, “Lack of metformin effect on mouse embryo AMPK activity: implications for metformin treatment during pregnancy,” Diabetes/Metabolism Research and Reviews, vol. 30, no. 1, pp. 23–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Owen, E. Doran, and A. P. Halestrap, “Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain,” Biochemical Journal, vol. 348, no. 3, pp. 607–614, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Brunmair, K. Staniek, F. Gras et al., “Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?” Diabetes, vol. 53, no. 4, pp. 1052–1059, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Carvalho, S. Correia, M. S. Santos, R. Seiça, C. R. Oliveira, and P. I. Moreira, “Metformin promotes isolated rat liver mitochondria impairment,” Molecular and Cellular Biochemistry, vol. 308, no. 1-2, pp. 75–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. R. Vinothkumar, J. Zhu, and J. Hirst, “Architecture of mammalian respiratory complex I,” Nature, vol. 515, no. 7525, pp. 80–84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. F. Turrens and A. Boveris, “Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria,” Biochemical Journal, vol. 191, no. 2, pp. 421–427, 1980. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Kushnareva, A. N. Murphy, and A. Andreyev, “Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state,” Biochemical Journal, vol. 368, no. 2, pp. 545–553, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Algire, O. Moiseeva, X. Deschênes-Simard et al., “Metformin reduces endogenous reactive oxygen species and associated DNA damage,” Cancer Prevention Research, vol. 5, no. 4, pp. 536–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Kelly, G. M. Tannahill, M. P. Murphy, and L. A. J. O'Neill, “Metformin inhibits the production of reactive oxygen species from NADH:ubiquinone oxidoreductase to limit induction of interleukin-1β (IL-1β) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages,” The Journal of Biological Chemistry, vol. 290, no. 33, pp. 20348–20359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. K. L. Jones, S. Arslanian, V. A. Peterokova, J.-S. Park, and M. J. Tomlinson, “Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial,” Diabetes Care, vol. 25, no. 1, pp. 89–94, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. B. U. Nwosu, L. Maranda, K. Cullen et al., “A randomized, double-blind, placebo-controlled trial of adjunctive metformin therapy in Overweight/Obese youth with type 1 diabetes,” PLoS ONE, vol. 10, no. 9, Article ID e0137525, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. I. M. Libman, K. M. Miller, L. A. DiMeglio et al., “Effect of metformin added to insulin on glycemic control among overweight/obese adolescents with type 1 diabetes a randomized clinical trial,” The Journal of the American Medical Association, vol. 314, no. 21, pp. 2241–2250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kaul, M. Apostolopoulou, and M. Roden, “Insulin resistance in type 1 diabetes mellitus,” Metabolism, vol. 64, no. 12, pp. 1629–1639, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Bloch-Damti and N. Bashan, “Proposed mechanisms for the induction of insulin resistance by oxidative stress,” Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1553–1567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Arany, N. Lebrasseur, C. Morris et al., “The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle,” Cell Metabolism, vol. 5, no. 1, pp. 35–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Yagi, “Simple assay for the level of total lipid peroxides in serum or plasma,” Methods in Molecular Biology, vol. 108, pp. 101–106, 1998. View at Google Scholar · View at Scopus
  27. S. F. Leong and J. B. Clark, “Regional enzyme development in rat brain. Enzymes associated with glucose utilization,” Biochemical Journal, vol. 218, no. 1, pp. 131–138, 1984. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Carlberg and B. Mannervik, “Glutathione reductase,” Methods in Enzymology, vol. 113, pp. 484–490, 1985. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Mannervik, “Glutathione peroxidase,” Methods in Enzymology, vol. 113, pp. 490–495, 1985. View at Publisher · View at Google Scholar · View at Scopus
  30. R. W. Browne and D. Armstrong, “Reduced glutathione and glutathione disulfide,” Methods in Molecular Biology, vol. 108, pp. 347–352, 1998. View at Google Scholar · View at Scopus
  31. H. Towbin, T. Staehelin, and J. Gordon, “Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979,” Biotechnology, vol. 24, pp. 145–149, 1992. View at Google Scholar · View at Scopus
  32. Y. Sun, T. T. Chiu, K. P. Foley, P. J. Bilan, and A. Klip, “Myosin Va mediates Rab8A-regulated GLUT4 vesicle exocytosis in insulin-stimulated muscle cells,” Molecular Biology of the Cell, vol. 25, no. 7, pp. 1159–1170, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Piwkowska, D. Rogacka, M. Jankowski, M. H. Dominiczak, J. K. Stepiński, and S. Angielski, “Metformin induces suppression of NAD(P)H oxidase activity in podocytes,” Biochemical and Biophysical Research Communications, vol. 393, no. 2, pp. 268–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Ouslimani, J. Peynet, D. Bonnefont-Rousselot, P. Thérond, A. Legrand, and J.-L. Beaudeux, “Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells,” Metabolism: Clinical and Experimental, vol. 54, no. 6, pp. 829–834, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Wessels, J. Ciapaite, N. M. A. Van Den Broek, K. Nicolay, and J. J. Prompers, “Metformin impairs mitochondrial function in skeletal muscle of both lean and diabetic rats in a dose-dependent manner,” PLoS ONE, vol. 9, no. 6, Article ID e100525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Okamoto, G. F. Anhê, R. Sabino-Silva et al., “Intensive insulin treatment induces insulin resistance in diabetic rats by impairing glucose metabolism-related mechanisms in muscle and liver,” Journal of Endocrinology, vol. 211, no. 1, pp. 55–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. D. Faichney and P. W. Tate, “Metformin in type 1 diabetes: is this a good or bad idea?” Diabetes Care, vol. 26, no. 5, p. 1655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Nakae, T. Kitamura, W. Ogawa, M. Kasuga, and D. Accili, “Insulin regulation of gene expression through the forkhead transcription factor foxol (Fkhr) requires kinases distinct from Akt,” Biochemistry, vol. 40, no. 39, pp. 11768–11776, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Meyer, P. Bohme, I. Delbachian et al., “The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients,” Diabetes Care, vol. 25, no. 12, pp. 2153–2158, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Zang, A. Zuccollo, X. Hou et al., “AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells,” The Journal of Biological Chemistry, vol. 279, no. 46, pp. 47898–47905, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Yano, G. Hasegawa, M. Ishii et al., “Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia,” Redox Report, vol. 9, no. 2, pp. 111–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Akhileshwar, S. P. Patel, and S. S. Katyare, “Diabetic cardiomyopathy and reactive oxygen species (ROS) related parameters in male and female rats: a comparative study,” Indian Journal of Clinical Biochemistry, vol. 22, no. 1, pp. 84–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Manea, E. Constantinescu, D. Popov, and M. Raicu, “Changes in oxidative balance in rat pericytes exposed to diabetic conditions,” Journal of Cellular and Molecular Medicine, vol. 8, no. 1, pp. 117–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Kawamori, H. Kaneto, Y. Nakatani et al., “The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation,” The Journal of Biological Chemistry, vol. 281, no. 2, pp. 1091–1098, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Erol, “Insulin resistance is an evolutionarily conserved physiological mechanism at the cellular level for protection against increased oxidative stress,” BioEssays, vol. 29, no. 8, pp. 811–818, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Detaille, B. Guigas, X. Leverve, N. Wiernsperger, and P. Devos, “Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function,” Biochemical Pharmacology, vol. 63, no. 7, pp. 1259–1272, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. R. A. Miller and M. J. Birnbaum, “An energetic tale of AMPK-independent effects of metformin,” The Journal of Clinical Investigation, vol. 120, no. 7, pp. 2267–2270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. U. Krengel and S. Törnroth-Horsefield, “Coping with oxidative stress,” Science, vol. 347, no. 6218, pp. 125–126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. S. P. Albracht, A. J. Meijer, and J. Rydström, “Mammalian NADH:ubiquinone oxidoreductase (Complex I) and nicotinamide nucleotide transhydrogenase (Nnt) together regulate the mitochondrial production of H2O2—implications for their role in disease, especially cancer,” Journal of Bioenergetics and Biomembranes, vol. 43, no. 5, pp. 541–564, 2011. View at Google Scholar
  50. Z. Zhang, Z. Yang, B. Zhu et al., “Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose,” PLoS ONE, vol. 7, no. 11, Article ID e49128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Machha, F. I. Achike, A. M. Mustafa, and M. R. Mustafa, “Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas,” Nitric Oxide, vol. 16, no. 4, pp. 442–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Nakhaee, M. Bokaeian, M. Saravani, A. Farhangi, and A. Akbarzadeh, “Attenuation of oxidative stress in streptozotocin-induced diabetic rats by Eucalyptus globulus,” Indian Journal of Clinical Biochemistry, vol. 24, no. 4, pp. 419–425, 2009. View at Publisher · View at Google Scholar
  53. O. Savu, C. Ionescu-Tirgoviste, V. Atanasiu, L. Gaman, R. Papacocea, and I. Stoian, “Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus,” Journal of International Medical Research, vol. 40, no. 2, pp. 709–716, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. R. K. Sundaram, A. Bhaskar, S. Vijayalingam, M. Viswanathan, R. Mohan, and K. R. Shanmugasundaram, “Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications,” Clinical Science, vol. 90, no. 4, pp. 255–260, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Büyükkoçak, H. S. Öztürk, M. N. Tamer, M. Kaçmaz, M. Y. B. Çimen, and I. Durak, “Erythrocyte oxidant/antioxidant status of diabetic patients,” Journal of Endocrinological Investigation, vol. 23, no. 4, pp. 228–230, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Gul, D. E. Laaksonen, M. Atalay, L. Vider, and O. Hänninen, “Effects of endurance training on tissue glutathione homeostasis and lipid peroxidation in streptozotocin-induced diabetic rats,” Scandinavian Journal of Medicine and Science in Sports, vol. 12, no. 3, pp. 163–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. G.-Q. Chen, K.-R. Lü, Y.-Q. Yang, S. Wang, and M.-J. Bie, “Effects of oxidative stress on MuRF1 expression in skeletal muscle of diabetic rats,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 42, no. 3, pp. 349–352, 2011. View at Google Scholar · View at Scopus
  58. P. Dey, M. R. Saha, S. R. Chowdhuri et al., “Assessment of anti-diabetic activity of an ethnopharmacological plant Nerium oleander through alloxan induced diabetes in mice,” Journal of Ethnopharmacology, vol. 161, pp. 128–137, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. A. P. Russell, G. Gastaldi, E. Bobbioni-Harsch et al., “Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids?” FEBS Letters, vol. 551, no. 1-3, pp. 104–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. E. Chang and J. Abe, “Kinase-SUMO networks in diabetes-mediated cardiovascular disease,” Metabolism, vol. 65, no. 5, pp. 623–633, 2016. View at Publisher · View at Google Scholar
  61. M. Nyberg, L. Gliemann, and Y. Hellsten, “Vascular function in health, hypertension, and diabetes: effect of physical activity on skeletal muscle microcirculation,” Scandinavian Journal of Medicine and Science in Sports, vol. 25, supplement 4, pp. 60–73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. C. H. Hung, S. H. Chan, P. M. Chu, H. C. Lin, and K. L. Tsai, “Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling,” Oncotarget, vol. 7, no. 10, pp. 10773–10787, 2016. View at Publisher · View at Google Scholar